Archimedes SPRL
Archimedes reported total assets of 76,775 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Nov 2025).
The score of Archimedes shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +153 % Total assets +60 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Archimedes's annual accounts
Filed annual accounts
- Year ended 30 Apr 2025filed on 11 Nov 2025
- Year ended 30 Apr 2024filed on 11 Nov 2025
- Year ended 30 Apr 2023filed on 11 Nov 2025
- Year ended 30 Apr 2022filed on 11 Nov 2025
- Year ended 30 Apr 2021filed on 10 Nov 2025
Archimedes's financial analysis
- Solvency84.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Archimedes
Archimedes's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0457.013.322
- VAT number
- BE0457013322
- Peppol
- Registered · 0208:0457013322 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 22 Jan 1996
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 11 Nov 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Archimedes (SPRL) has been based in Mol since 1996, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 38,387 € and equity of 64,898 €; its revenue is not published. Its solvency stands at 84.5%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Archimedes
Companies in the same business, of comparable size and area, outside its group.
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- Orthophysics Manufacture of medical and dental instruments and supplies Hooglede · balance sheet €2.78m
- Global Health Support Wholesale of pharmaceutical and medical goods Esneux · balance sheet 201,247 €
- Roller Wholesale of pharmaceutical and medical goods Willebroek · balance sheet 167,766 €
- Stellify Trade Activities of agents involved in non-specialised wholesale Malle · balance sheet 78,374 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Yourope Trading Wholesale of pharmaceutical and medical goods Brussels · balance sheet 89,184 €
- ACDcure Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet 17,329 €
Frequently asked questions about Archimedes
What is the revenue of Archimedes?
Archimedes files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Archimedes?
In Belgium, the VAT number is the company number prefixed with BE: BE0457013322 for Archimedes, if the company is VAT-registered. Its company number (CBE) is 0457.013.322.
Where is the registered office of Archimedes?
According to the CBE register, the registered office of Archimedes is in 2400 Mol.
What is the equity of Archimedes?
At the close of the 2025 financial year, the equity of Archimedes amounts to 64,898 €, a solvency of 84.5% of total assets.
Who manages Archimedes?
The register lists 2 active mandates at Archimedes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Archimedes
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →